The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
Modulation of monocyte-endothelial cell interactions by platelet microparticles.
Open accessAbstract
Platelets, activated by various agonists, produce microparticles (MP) from the plasma membrane, which are released into the extracellular space. Although the mechanism of MP formation has been clarified, their biological importance remains ill defined. We have recently shown that platelet-derived MP influence platelet and endothelial cell function. In this study, we have further examined the mechanism of cellular activation by platelet MP. To address the possibility that they may influence monocyte-endothelial interactions, we used an in vitro assay to examine their effects on the adhesion of monocytes to human umbilical vein endothelial cells (HUVEC). Platelet MP increased the adhesion of monocytes to HUVEC in a time- and dose-dependent manner. Maximal adhesion of monocytes to resting HUVEC was observed after 24 h of stimulation with MP. Similar kinetics were observed with U-937 (human promonocytic leukemia) cells, used as a model for the blood-borne monocyte. Maximal adhesion of resting monocytes to MP-stimulated HUVEC was observed after 5 h of stimulation with MP. The EC50s for MP-induced increases in HUVEC, monocyte, and U-937 cell adhesion is 8.74, 43.41, and 10.83 microg/ml of MP protein, respectively. The induction of monocyte-endothelial adhesion was mimicked by arachidonic acid isolated from MP. The observed increased cellular adhesiveness correlated with MP-induced upregulation of cell adhesion molecules. MP-stimulated HUVEC increased intracellular cell adhesion molecule-1 (ICAM-1) but not vascular cell adhesion molecule-1 (VCAM-1), P-, or E-selectin expression. Monocyte and U-937 lymphocyte function-associated antigen-1 (CD11a/CD18) and macrophage antigen-1 (CD11b/ CD18, alpham/beta2) were both upregulated upon MP stimulation, but an increase in p150,95 (CD11c/CD18), very late antigen-1, or ICAM-1 expression was not observed. The functional importance of these changes was demonstrated with blocking antibodies. MP also induced the chemotaxis of U-937 cells in a dose-dependent manner with an EC50 of 4.40 microg/ml of MP protein. Similarly, arachidonic acid isolated from MP mimicked the chemotactic response. A role for PKC was implicated in both adhesion and chemotaxis. GF 109203X, a specific inhibitor of PKC, significantly reduced monocyte-endothelial adhesion, as well as U-937 chemotaxis. The demonstration that platelet MP may modulate important aspects of endothelial and monocyte function provides a novel mechanism by which platelets may interact with such cells in human atherosclerosis and inflammation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A RAPID METHOD OF TOTAL LIPID EXTRACTION AND PURIFICATION
Bligh, E. G., & Dyer, W. J. (1959) · Canadian Journal of Biochemistry and Physiology · doi:10.1139/o59-099 · Cited by 54,751
Isolation of mononuclear cells and granulocytes from human blood.
Bøyum, A. (1968) · Scandinavian Journal of Clinical and Laboratory Investigation · Cited by 9,585
Jaffe, E. A., Nachman, R. L., Becker, C. G., & Minick, C. R. (1973) · Journal of Clinical Investigation · doi:10.1172/jci107470 · Cited by 6,856
Adhesion receptors of the immune system
Springer, T. A. (1990) · Nature · doi:10.1038/346425a0 · Cited by 6,477
The bisindolylmaleimide GF 109203X is a potent and selective inhibitor of protein kinase C
Toullec, D., Pianetti, P., Coste, H., Bellevergue, P., Grand-Perret, T., Ajakane, M., Baudet, V., Boissin, P., Boursier, E., & Loriolle, F. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)98476-0 · Cited by 2,456
Establishment and characterization of a human histiocytic lymphoma cell line (U‐937)
Sundström, C., & Nilsson, K. (1976) · International Journal of Cancer · doi:10.1002/ijc.2910170504 · Cited by 2,407
Onuegbu, A. J., Olisekodiaka, J. M., Udo, J. U., Umeononihu, O., Amah, U. K., Okwara, J. E., & Atuegbu, C. (2015) · Medical Principles and Practice · doi:10.1159/000381778 · Cited by 2,044
Pober, J. S., Gimbrone, M. A., Lapierre, L. A., Mendrick, D. L., Fiers, W., Rothlein, R., & Springer, T. A. (1986) · The Journal of Immunology · doi:10.4049/jimmunol.137.6.1893 · Cited by 1,413
In vitro methods in cell-mediated and tumor immunity
Bloom, B. R., & David, J. R. (1976) · Academic Press eBooks · Cited by 1,273
Cited by
Exosomes: Extracellular organelles important in intercellular communication
Mathivanan, S., Ji, H., & Simpson, R. J. (2010) · Journal of Proteomics · doi:10.1016/j.jprot.2010.06.006 · Cited by 2,537
Platelet Activation and Atherothrombosis
Davì, G., & Patrono, C. (2007) · New England Journal of Medicine · doi:10.1056/nejmra071014 · Cited by 2,135
Classification, Functions, and Clinical Relevance of Extracellular Vesicles
van der Pol, E., Böing, A. N., Harrison, P., Sturk, A., & Nieuwland, R. (2012) · Pharmacological Reviews · doi:10.1124/pr.112.005983 · Cited by 1,754
Cytokines in Atherosclerosis: Pathogenic and Regulatory Pathways
Tedgui, A., & Mallat, Z. (2006) · Physiological Reviews · doi:10.1152/physrev.00024.2005 · Cited by 1,701
Ratajczak, J., Wysoczynski, M., Hayek, F., Janowska-Wieczorek, A., & Ratajczak, M. Z. (2006) · Leukemia · doi:10.1038/sj.leu.2404296 · Cited by 1,340
Exosomes/microvesicles as a mechanism of cell-to-cell communication
Camussi, G., Deregibus, M. C., Bruno, S., Cantaluppi, V., & Biancone, L. (2010) · Kidney International · doi:10.1038/ki.2010.278 · Cited by 1,178
Circulating microparticles: pathophysiology and clinical implications
Piccin, A., Murphy, W. G., & Smith, O. P. (2007) · Blood Reviews · doi:10.1016/j.blre.2006.09.001 · Cited by 799
Role of Prostacyclin in the Cardiovascular Response to Thromboxane A 2
Cheng, Y., Austin, S. C., Rocca, B., Koller, B. H., Coffman, T. M., Grosser, T., Lawson, J. A., & FitzGerald, G. A. (2002) · Science · doi:10.1126/science.1068711 · Cited by 789
Self-citationMicroparticles: Protagonists of a Novel Communication Network for Intercellular Information Exchange
Mause, S. F., & Weber, C. (2010) · Circulation Research · doi:10.1161/circresaha.110.226456 · Cited by 786
Microvesicles derived from activated platelets induce metastasis and angiogenesis in lung cancer
Janowska‐Wieczorek, A., Wysoczynski, M., Kijowski, J., Marquez‐Curtis, L., Machalinski, B., Ratajczak, J., & Ratajczak, M. Z. (2005) · International Journal of Cancer · doi:10.1002/ijc.20657 · Cited by 768
Combes, V., Simon, A.-C., Grau, G.-E., Arnoux, D., Camoin, L., Sabatier, F., Mutin, M., Sanmarco, M., Sampol, J., & Dignat-George, F. (1999) · Journal of Clinical Investigation · doi:10.1172/jci4985 · Cited by 732
The platelet contribution to cancer progression
BAMBACE, N. M., & HOLMES, C. E. (2011) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2010.04131.x · Cited by 705
Immunological processes in malaria pathogenesis
Schofield, L., & Grau, G. E. (2005) · Nature Reviews Immunology · doi:10.1038/nri1686 · Cited by 688
Microparticles in cardiovascular diseases
VANWIJK, M., VANBAVEL, E., STURK, A., & NIEUWLAND, R. (2003) · Cardiovascular Research · doi:10.1016/s0008-6363(03)00367-5 · Cited by 610
Mack, M., Kleinschmidt, A., Brühl, H., Klier, C., Nelson, P. J., Cihak, J., Plachý, J., Stangassinger, M., Erfle, V., & Schlöndorff, D. (2000) · Nature Medicine · doi:10.1038/77498 · Cited by 605
Platelet‐Rich Plasma: Growth Factors and Pro‐ and Anti‐Inflammatory Properties
El‐Sharkawy, H., Kantarci, A., Deady, J., Hasturk, H., Liu, H., Alshahat, M., & Van Dyke, T. E. (2007) · Journal of Periodontology · doi:10.1902/jop.2007.060302 · Cited by 585
Extracellular vesicles in coronary artery disease
Boulanger, C. M., Loyer, X., Rautou, P.-E., & Amabile, N. (2017) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2017.7 · Cited by 514
Circulating Microparticles From Patients With Myocardial Infarction Cause Endothelial Dysfunction
Boulanger, C. M., Scoazec, A., Ebrahimian, T., Henry, P., Mathieu, E., Tedgui, A., & Mallat, Z. (2001) · Circulation · doi:10.1161/hc4701.100516 · Cited by 510
Exosomes: New players in cell–cell communication
Bang, C., & Thum, T. (2012) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2012.08.007 · Cited by 505
Effects of Severe Hypertension on Endothelial and Platelet Microparticles
Preston, R. A., Jy, W., Jimenez, J. J., Mauro, L. M., Horstman, L. L., Valle, M., Aime, G., & Ahn, Y. S. (2003) · Hypertension · doi:10.1161/01.hyp.0000049760.15764.2d · Cited by 499
Turturici, G., Tinnirello, R., Sconzo, G., & Geraci, F. (2014) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00228.2013 · Cited by 483
“EVs also contain bioactive lipids, including sphingosine 1-phosphate and arachidonic acid, which induce several biological responses in target cells (16, 17, 139).”
BackgroundProcoagulant Microparticles: Disrupting the Vascular Homeostasis Equation?
Morel, O., Toti, F., Hugel, B., Bakouboula, B., Camoin-Jau, L., Dignat-George, F., & Freyssinet, J.-M. (2006) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000246775.14471.26 · Cited by 460
Cellular microparticles: a disseminated storage pool of bioactive vascular effectors
Morel, O., Toti, F., Hugel, B., & Freyssinet, J.-M. (2004) · Current Opinion in Hematology · doi:10.1097/01.moh.0000131441.10020.87 · Cited by 454
Platelet-derived microparticles induce angiogenesis and stimulate post-ischemic revascularization
BRILL, A., DASHEVSKY, O., RIVO, J., GOZAL, Y., & VARON, D. (2005) · Cardiovascular Research · doi:10.1016/j.cardiores.2005.04.007 · Cited by 433
Cell-derived microparticles in haemostasis and vascular medicine
Burnier, L., Fontana, P., Kwak, B. R., & Angelillo-Scherrer, A. (2009) · Thrombosis and Haemostasis · doi:10.1160/th08-08-0521 · Cited by 416
Platelets: signaling cells in the immune continuum
Weyrich, A. S., & Zimmerman, G. A. (2004) · Trends in Immunology · doi:10.1016/j.it.2004.07.003 · Cited by 414
Role of Monocytes in Atherogenesis
ØSTERUD, B., & BJØRKLID, E. (2003) · Physiological Reviews · doi:10.1152/physrev.00005.2003 · Cited by 412
Microvesicles as Cell–Cell Messengers in Cardiovascular Diseases
Loyer, X., Vion, A.-C., Tedgui, A., & Boulanger, C. M. (2014) · Circulation Research · doi:10.1161/circresaha.113.300858 · Cited by 408
Platelet P-selectin facilitates atherosclerotic lesion development
Burger, P. C., & Wagner, D. D. (2003) · Blood · doi:10.1182/blood-2002-07-2209 · Cited by 407
Platelet-Mediated Modulation of Adaptive Immunity
Elzey, B. D., Tian, J., Jensen, R. J., Swanson, A. K., Lees, J. R., Lentz, S. R., Stein, C. S., Nieswandt, B., Wang, Y., Davidson, B. L., et al. (2003) · Immunity · doi:10.1016/s1074-7613(03)00177-8 · Cited by 401
Cellular microparticles: what are they bad or good for?
Freyssinet, J.-M. (2003) · Journal of Thrombosis and Haemostasis · doi:10.1046/j.1538-7836.2003.00309.x · Cited by 399
Mause, S. F., von Hundelshausen, P., Zernecke, A., Koenen, R. R., & Weber, C. (2005) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000170133.43608.37 · Cited by 387
Endothelium-derived microparticles impair endothelial function in vitro
Brodsky, S. V., Zhang, F., Nasjletti, A., & Goligorsky, M. S. (2004) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01172.2003 · Cited by 379
Microparticles, Vascular Function, and Atherothrombosis
Rautou, P.-E., Vion, A.-C., Amabile, N., Chironi, G., Simon, A., Tedgui, A., & Boulanger, C. M. (2011) · Circulation Research · doi:10.1161/circresaha.110.233163 · Cited by 376
Cellular microparticles: new players in the field of vascular disease?
Diamant, M., Tushuizen, M. E., Sturk, A., & Nieuwland, R. (2004) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2004.01355.x · Cited by 364
Microparticles: biomarkers and beyond
Burger, D., Schock, S., Thompson, C. S., Montezano, A. C., Hakim, A. M., & Touyz, R. M. (2013) · Clinical Science · doi:10.1042/cs20120309 · Cited by 362
Diamant, M., Nieuwland, R., Pablo, R. F., Sturk, A., Smit, J. W. A., & Radder, J. K. (2002) · Circulation · doi:10.1161/01.cir.0000036596.59665.c6 · Cited by 359
Exosomes and microvesicles in normal physiology, pathophysiology, and renal diseases
Ståhl, A.-L., Johansson, K., Mossberg, M., Kahn, R., & Karpman, D. (2019) · Pediatric Nephrology · doi:10.1007/s00467-017-3816-z · Cited by 356
Schober, A., Manka, D., von Hundelshausen, P., Huo, Y., Hanrath, P., Sarembock, I. J., Ley, K., & Weber, C. (2002) · Circulation · doi:10.1161/01.cir.0000028590.02477.6f · Cited by 355
Janowska-Wieczorek, A., Majka, M., Kijowski, J., Baj-Krzyworzeka, M., Reca, R., Turner, A. R., Ratajczak, J., Emerson, S. G., Kowalska, M. A., & Ratajczak, M. Z. (2001) · Blood · doi:10.1182/blood.v98.10.3143 · Cited by 354
Mesri, M., & Altieri, D. C. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.33.23111 · Cited by 349
Rozmyslowicz, T., Majka, M., Kijowski, J., Murphy, S. L., Conover, D. O., Poncz, M., Ratajczak, J., Gaulton, G. N., & Ratajczak, M. Z. (2003) · AIDS · doi:10.1097/00002030-200301030-00006 · Cited by 337
Baj-Krzyworzeka, M., Majka, M., Pratico, D., Ratajczak, J., Vilaire, G., Kijowski, J., Reca, R., Janowska-Wieczorek, A., & Ratajczak, M. Z. (2002) · Experimental Hematology · doi:10.1016/s0301-472x(02)00791-9 · Cited by 329
Distler, J. H. W., Jüngel, A., Huber, L. C., Seemayer, C. A., Reich, C. F., Gay, R. E., Michel, B. A., Fontana, A., Gay, S., Pisetsky, D. S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0409781102 · Cited by 328
The role of microparticles in the pathogenesis of rheumatic diseases
Beyer, C., & Pisetsky, D. S. (2010) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2009.229 · Cited by 324
Ratajczak, M. Z., Kucia, M., Jadczyk, T., Greco, N. J., Wojakowski, W., Tendera, M., & Ratajczak, J. (2012) · Leukemia · doi:10.1038/leu.2011.389 · Cited by 324
Simak, J., & Gelderman, M. P. (2006) · Transfusion Medicine Reviews · doi:10.1016/j.tmrv.2005.08.001 · Cited by 314
Platelets as Cellular Effectors of Inflammation in Vascular Diseases
Rondina, M. T., Weyrich, A. S., & Zimmerman, G. A. (2013) · Circulation Research · doi:10.1161/circresaha.113.300512 · Cited by 312
Hulsmans, M., & Holvoet, P. (2013) · Cardiovascular Research · doi:10.1093/cvr/cvt161 · Cited by 308
Nomura, S., Tandon, N. N., Nakamura, T., Cone, J., Fukuhara, S., & Kambayashi, J. (2001) · Atherosclerosis · doi:10.1016/s0021-9150(01)00433-6 · Cited by 304
The Platelet Microparticle Proteome
Garcia, B. A., Smalley, D. M., Cho, Shabanowitz, J., Ley, K., & Hunt, D. F. (2005) · Journal of Proteome Research · doi:10.1021/pr0500760 · Cited by 297
Huber, J., Vales, A., Mitulovic, G., Blumer, M., Schmid, R., Witztum, J. L., Binder, B. R., & Leitinger, N. (2002) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/hq0102.101525 · Cited by 296
Extracellular vesicles in renal disease
Karpman, D., Ståhl, A.-L., & Arvidsson, I. (2017) · Nature Reviews Nephrology · doi:10.1038/nrneph.2017.98 · Cited by 295
The innate immune response in reperfused myocardium
Timmers, L., Pasterkamp, G., de Hoog, V. C., Arslan, F., Appelman, Y., & de Kleijn, D. P. V. (2012) · Cardiovascular Research · doi:10.1093/cvr/cvs018 · Cited by 291
Endothelial Dysfunction Caused by Circulating Microparticles from Patients with Metabolic Syndrome
Agouni, A., Lagrue-Lak-Hal, A. H., Ducluzeau, P. H., Mostefai, H. A., Draunet-Busson, C., Leftheriotis, G., Heymes, C., Martinez, M. C., & Andriantsitohaina, R. (2008) · The American Journal of Pathology · doi:10.2353/ajpath.2008.080228 · Cited by 289
Clinical relevance of microparticles from platelets and megakaryocytes
Italiano, J. E., Mairuhu, A. T., & Flaumenhaft, R. (2010) · Current Opinion in Hematology · doi:10.1097/moh.0b013e32833e77ee · Cited by 289
Sabatier, F., Roux, V., Anfosso, F., Camoin, L., Sampol, J., & Dignat-George, F. (2002) · Blood · doi:10.1182/blood.v99.11.3962 · Cited by 288
Proteogenomic analysis reveals exosomes are more oncogenic than ectosomes
Keerthikumar, S., Gangoda, L., Liem, M., Fonseka, P., Atukorala, I., Ozcitti, C., Mechler, A., Adda, C. G., Ang, C.-S., & Mathivanan, S. (2015) · Oncotarget · doi:10.18632/oncotarget.3801 · Cited by 270
Platelets and Chemokines in Atherosclerosis: Partners in Crime
Weber, C. (2005) · Circulation Research · doi:10.1161/01.res.0000160077.17427.57 · Cited by 265
Platelet activation in obesity and metabolic syndrome
Santilli, F., Vazzana, N., Liani, R., Guagnano, M. T., & Davì, G. (2012) · Obesity Reviews · doi:10.1111/j.1467-789x.2011.00930.x · Cited by 258
Rautou, P.-E., Leroyer, A. S., Ramkhelawon, B., Devue, C., Duflaut, D., Vion, A.-C., Nalbone, G., Castier, Y., Leseche, G., Lehoux, S., et al. (2011) · Circulation Research · doi:10.1161/circresaha.110.237420 · Cited by 255
Choi, Y. Y., Kim, A., Lee, Y., Lee, Y. H., Park, M., Shin, E., Park, S., Youn, B., & Seong, K. M. (2023) · Journal of Extracellular Vesicles · doi:10.1002/jev2.12325 · Cited by 44
Extracellular vesicles and lipoproteins – Smart messengers of blood cells in the circulation
Nguyen, P. H. D., Le, A. H., Pek, J. S. Q., Pham, T. T., Jayasinghe, M. K., Do, D. V., Phung, C. D., & Le, M. T. N. (2022) · Journal of Extracellular Biology · doi:10.1002/jex2.49 · Cited by 31
Metadata
- Authors
- Barry, O. P., Praticò, D., Savani, R. C., & FitzGerald, G. A.
- Venue
- Journal of Clinical Investigation
- Published
- 1998-07-01
- Volume
- 102
- Issue
- 1
- Pages
- 136-144
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W1965056341
- Cited by
- 544
- References
- 52
- FWCI
- 6.30
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.